Assessing Aspirin for Primary CVD Prevention

Authors

Jelena Lewis, Chapman UniversityFollow
Laressa Bethishou, Chapman UniversityFollow
Laura V. Tsu, Chapman UniversityFollow

Document Type

Article

Publication Date

2-2019

Abstract

Aspirin has been used for various indications for many years. It also may play a role in primary and secondary prevention of cardiovascular disease. The vast majority of evidence supports the use of aspirin for secondary prevention. However, for primary prevention, the use of aspirin is debatable. Three studies published recently address the issue of aspirin use in primary prevention. Based on the results of these studies, the use of aspirin for primary prevention remains controversial, and its use in this role should be individualized.

Comments

This article was originally published in US Pharmacist, volume 44, issue 2, in 2019.

Recommended Citation

Lewis J, Bethishou L, Tsu LB. Assessing aspirin for primary CVD prevention. US Pharmacist. 2019;44(2):37-44.

Copyright

US Pharmacist